Search Results

There are 9269 results for: content related to: Another drug in the armamentarium to combat hepatitis B virus in adolescents

  1. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  2. Tenofovir: A Nucleotide Analog for The Management of Human Immunodeficiency Virus Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 1, January 2003, Pages: 29–43, Tony Antoniou, Laura Y. Park-Wyllie and Alice L. Tseng

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.1.29.31915

  3. You have free access to this content
    The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir

    HIV Medicine

    Volume 15, Issue 8, September 2014, Pages: 505–510, J Young, Q Wang, CA Fux, E Bernasconi, H Furrer, P Vernazza, A Calmy, M Cavassini, R Weber, M Battegay, HC Bucher and and theSwiss HIV Cohort Study

    Version of Record online : 18 MAR 2014, DOI: 10.1111/hiv.12149

  4. You have full text access to this OnlineOpen article
    International Congress of Drug Therapy in HIV Infection 2-6 November 2014, Glasgow, UK

    Journal of the International AIDS Society

    Volume 17, Issue 4S3, November 2014,

    Version of Record online : 2 NOV 2014, DOI: 10.7448/IAS.17.4.19856

  5. Drug-Drug and Drug-Food Interactions Between Tenofovir Disoproxil Fumarate and Didanosine

    The Journal of Clinical Pharmacology

    Volume 45, Issue 12, December 2005, Pages: 1360–1367, Dr Brian P. Kearney, Dr John R. Sayre, Dr John F. Flaherty, Mr. Shan-Shan Chen, Dr Sanjeev Kaul and Dr Andrew K. Cheng

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270005281351

  6. A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 288–297, Shan-Ru Zuo, Xiao-Cong Zuo, Chun-Jiang Wang, Yu-Tao Ma, Hao-Ye Zhang, Zuo-Jun Li, Li-Ying Song, Zhen-Zhen Deng and Shi-Kun Liu

    Version of Record online : 20 NOV 2014, DOI: 10.1002/jcph.409

  7. You have free access to this content
    Randomized, placebo-controlled trial of tenofovir disoproxil fumarate in adolescents with chronic hepatitis B

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2018–2026, Karen F. Murray, Leszek Szenborn, Jacek Wysocki, Stephen Rossi, Amoreena C. Corsa, Phillip Dinh, John McHutchison, Phillip S. Pang, Luminita M. Luminos, Malgorzata Pawlowska and Jacek Mizerski

    Version of Record online : 27 AUG 2012, DOI: 10.1002/hep.25818

  8. Steady-State Pharmacokinetics of Emtricitabine and Tenofovir Disoproxil Fumarate Administered Alone and in Combination in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 6, June 2007, Pages: 751–759, M. Robert Blum, Gregory E. Chittick, John A. Begley and Jian Zong

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007300951

  9. You have full text access to this OnlineOpen article
    International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

    Journal of the International AIDS Society

    Volume 19, Issue 8S7, October 2016,

    Version of Record online : 23 OCT 2016, DOI: 10.7448/IAS.19.8.21487

  10. Discovery and Development of Tenofovir Disoproxil Fumarate

    Antiviral Drugs: From Basic Discovery through Clinical Trials

    Wieslaw M. Kazmierski, Pages: 85–101, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9780470929353.ch7

  11. Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012)?

    Medicinal Research Reviews

    Volume 32, Issue 4, July 2012, Pages: 765–785, Erik De Clercq

    Version of Record online : 11 MAY 2012, DOI: 10.1002/med.21267

  12. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 6, June 2013, Pages: 1859–1868, Christopher Mcconville, David R. Friend, Meredith R. Clark and Karl Malcolm

    Version of Record online : 8 APR 2013, DOI: 10.1002/jps.23528

  13. Absence of Clinically Relevant Pharmacokinetic Interaction Between Ribavirin and Tenofovir in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 46, Issue 5, May 2006, Pages: 559–566, Srinivasan Ramanathan, Andrew Cheng, Angelique Mittan, Ramin Ebrahimi and Brian P. Kearney

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006287704

  14. You have full text access to this OnlineOpen article
    Eleventh International Congress on Drug Therapy in HIV Infection

    Journal of the International AIDS Society

    Volume 15, Issue S4, November 2012,

    Version of Record online : 11 NOV 2012, DOI: 10.7448/IAS.15.6.18447

  15. Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 2, February 2009, Pages: 182–189, D Hirt, S Urien, DK Ekouévi, E Rey, E Arrivé, S Blanche, C Amani-Bosse, E Nerrienet, G Gray, M Kone, SK Leang, J McIntyre, F Dabis and J-M Tréluyer

    Version of Record online : 5 NOV 2008, DOI: 10.1038/clpt.2008.201

  16. Maximized Mucoadhesion and Skin Permeation of Anti-AIDS-Loaded Niosomal Gels

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 3, March 2014, Pages: 952–964, Ahmed S. Zidan and Muhammad J. Habib

    Version of Record online : 24 JAN 2014, DOI: 10.1002/jps.23867

  17. Systemic and Renal Pharmacokinetics of Adefovir and Tenofovir Upon Coadministration

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 935–940, Brian P. Kearney, Srinivasan Ramanathan, Andrew K. Cheng, Ramin Ebrahimi and Jaymin Shah

    Version of Record online : 19 MAR 2013, DOI: 10.1177/0091270005278949

  18. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus

    Alimentary Pharmacology & Therapeutics

    Volume 45, Issue 12, June 2017, Pages: 1493–1505, M. H. Hyun, Y.-S. Lee, J. H. Kim, J. H. Je, Y. J. Yoo, J. E. Yeon and K. S. Byun

    Version of Record online : 24 APR 2017, DOI: 10.1111/apt.14068

  19. Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 38, Issue 2, April 2013, Pages: 136–140, C. Lu, Y. Jia, L. Chen, Y. Ding, J. Yang, M. Chen, Y. Song, X. Sun and A. Wen

    Version of Record online : 28 DEC 2012, DOI: 10.1111/jcpt.12023

  20. You have free access to this content
    Pharmacokinetics of tenofovir during pregnancy and postpartum

    HIV Medicine

    Volume 16, Issue 8, September 2015, Pages: 502–511, BM Best, S Burchett, H Li, A Stek, C Hu, J Wang, E Hawkins, M Byroads, DH Watts, E Smith, CV Fletcher, EV Capparelli, M Mirochnick and for the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) P1026s Team

    Version of Record online : 11 MAY 2015, DOI: 10.1111/hiv.12252